Outlook Wealth Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
Outlook Wealth Advisors's PBE Position: Q3 2026 in Review
Outlook Wealth Advisors opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 15,088 shares worth $1.47M. The stake represents 0.31% of the portfolio and ranks #74 among its holdings.
122 funds tracked by Wall St. Rank hold PBE as of Q3 2026.
- Outlook Wealth Advisors held 15,088 shares of Invesco Biotechnology & Genome ETF worth $1.47M as of Q3 2026.
- Invesco Biotechnology & Genome ETF was a new Outlook Wealth Advisors position in Q3 2026.
- Invesco Biotechnology & Genome ETF made up 0.31% of Outlook Wealth Advisors's portfolio in Q3 2026, its #74 holding.
- 122 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.
Based on Outlook Wealth Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.